Impel NeuroPharma Inc. Skyrocketed
Impel NeuroPharma Inc. (IMPL:NASDAQ) soared at $0.78, a gain of 143.4%. On Wed, Nov 22, 2023, IMPL:NASDAQ touched a New 2-Week High of $0.78. The stock appeared on our News Catalysts scanner on Mon, Oct 30, 2023 at 05:06 PM in the 'MISCELLANEOUS' category. From Wed, Nov 08, 2023, the stock recorded 40.00% Up Days and 54.55% Green Days
The stock spiked on Wed, Nov 22, 2023 at $1.06 with a volume of 26M+.
About Impel NeuroPharma Inc. (IMPL:NASDAQ)
Impel NeuroPharma Inc is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases...
Top 10 Gainers:
- Impel NeuroPharma Inc. (IMPL:NASDAQ), 143.44%
- AgileThought Inc. (AGIL:NASDAQ), 137.35%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 104.08%
- USD Partners LP (USDP:NYSE), 103.58%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 67.16%
- Marpai Inc. (MRAI:NASDAQ), 43.45%
- MoneyHero Limited (MNY:NASDAQ), 40.28%
- Conduit Pharmaceuticals Inc Com (CDT:NASDAQ), 38.46%
- POET Technologies Inc. (POET:NASDAQ), 35%
- AquaBounty Technologies, Inc. (AQB:NASDAQ), 33.54%